News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,050 Results
Type
Article (86897)
Company Profile (704)
Press Release (765448)
Multimedia
Podcasts (148)
Webinars (19)
Section
Business (232826)
Career Advice (4133)
Deals (39763)
Drug Delivery (130)
Drug Development (91113)
Employer Resources (199)
FDA (18192)
Job Trends (17367)
News (396866)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1573)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (403)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (394)
Cancer (3107)
Cardiovascular disease (249)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74338)
Collaboration (1115)
Company closure (3)
Compensation (715)
Complete response letters (34)
COVID-19 (2906)
CRISPR (68)
C-suite (359)
Cystic fibrosis (122)
Data (3105)
Decentralized trials (2)
Denatured (52)
Depression (78)
Diabetes (380)
Diagnostics (6982)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (184)
Drug pricing (153)
Drug shortages (36)
Duchenne muscular dystrophy (138)
Earnings (97539)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131483)
Executive appointments (910)
FDA (19946)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1020)
Gene editing (149)
Generative AI (40)
Gene therapy (439)
GLP-1 (937)
Government (5265)
Grass and pollen (6)
Guidances (182)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3103)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (56)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (58)
Layoffs (595)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (216)
Machine learning (12)
Management (65)
Manufacturing (449)
MASH (100)
Medical device (14733)
Medtech (14738)
Mergers & acquisitions (22586)
Metabolic disorders (969)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (145)
Neuropsychiatric disorders (43)
Neuroscience (2334)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (127)
Parkinson's disease (201)
Partnered (25)
Patents (323)
Patient recruitment (174)
Peanut (55)
People (65733)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22944)
Phase II (32278)
Phase III (24302)
Pipeline (1710)
Policy (246)
Postmarket research (3552)
Preclinical (10361)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (529)
Real estate (7402)
Recruiting (76)
Regulatory (27191)
Reports (62)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (99)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (66)
The Weekly (94)
Vaccines (919)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (95)
Last 7 days (411)
Last 30 days (2023)
Last 365 days (33998)
2025 (18589)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50546)
Australia (8879)
California (7813)
Canada (2422)
China (728)
Colorado (340)
Connecticut (349)
Delaware (205)
Europe (115961)
Florida (1161)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (744)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1109)
Massachusetts (5984)
Michigan (276)
Minnesota (488)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2195)
New Mexico (31)
New York (2193)
North Carolina (1250)
North Dakota (10)
Northern California (3366)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1667)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2896)
Tennessee (130)
Texas (1199)
United States (29521)
Utah (231)
Virginia (215)
Washington D.C. (80)
Washington State (692)
West Virginia (4)
Wisconsin (86)
There are 853,050 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
July 17, 2025
·
7 min read
Press Releases
Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress
July 17, 2025
·
6 min read
Press Releases
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy
July 17, 2025
·
8 min read
Press Releases
Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
July 17, 2025
·
2 min read
Press Releases
Cantargia Announces Preliminary Topline Efficacy Results From the Phase 2 TRIFOUR Trial of Nadunolimab in Advanced Triple-Negative Breast Cancer (TNBC)
July 17, 2025
·
6 min read
Press Releases
Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
July 17, 2025
·
1 min read
Press Releases
Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target
July 17, 2025
·
6 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress
July 17, 2025
·
10 min read
Press Releases
DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
July 17, 2025
·
11 min read
Press Releases
Alnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
July 17, 2025
·
1 min read
1 of 85,305
Next
